Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000153024 | SCV000202469 | benign | not specified | 2014-04-18 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000153024 | SCV000248023 | likely benign | not specified | 2014-06-05 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004019831 | SCV000320062 | benign | Familial thoracic aortic aneurysm and aortic dissection | 2017-05-31 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001172017 | SCV000565122 | likely benign | not provided | 2022-10-24 | criteria provided, single submitter | clinical testing | See Variant Classification Assertion Criteria. |
Invitae | RCV003761792 | SCV000754964 | benign | FG syndrome | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001172017 | SCV001334946 | likely benign | not provided | 2023-12-01 | criteria provided, single submitter | clinical testing | MED12: BS2 |
Prevention |
RCV003985282 | SCV004761115 | likely benign | MED12-related disorder | 2022-01-18 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |